BackLipella Pharmaceuticals Overview

Lipella Pharmaceuticals Current Assets

Lipella Pharmaceuticals's current assets is $2.1B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$2.08B
↓ 0.03% YoYΔ $-677000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Lipella Pharmaceuticals Current Assets History

Loading

Lipella Pharmaceuticals vs. peers: Current Assets Comparison

Loading

Lipella Pharmaceuticals Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lipella Pharmaceuticals (LIPO) FAQ

As of the most recent data (September 2025), LIPO shows a current assets of $2.1B. That compares with $2.1B in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LIPO's current assets is now $2.1B (was $2.1B) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Lipella Pharmaceuticals is outperforming or lagging.

Tracking LIPO's current assets over time shows whether Lipella Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $2.1B That compares with $2.1B in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Lipella Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $2.1B) with ownership activity and broader fundamentals.